Investor Sues Boston Scientific Over FDA's Mesh Product Pull

Law360 (April 24, 2019, 3:58 PM EDT) -- An investor sued Boston Scientific on Wednesday over the 7.7% drop in share price that followed the U.S. Food and Drug Administration's decision last week to pull the company's surgical mesh products from the U.S. market.

The FDA said on April 16 that the medical device manufacturer's premarket approval applications for its Uphold Lite Vaginal Support System and Xenform Soft Tissue Repair System lacked evidence guaranteeing the safety and long-term effectiveness of those products.

News that the products would be pulled from shelves in the U.S. caused Boston Scientific's share price to drop by $2.90, according to investor Steve Klein, who...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Attached Documents

Related Sections

Case Information

Case Title

Subscribers Only

Case Number

Subscribers Only

Court

Subscribers Only

Nature of Suit

Subscribers Only

Judge

Subscribers Only

Date Filed

Subscribers Only

Law Firms

Companies

Government Agencies